This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
TherOx, which makes a cardiovascular device that dissolves oxygen in the bloodstream post-heart attack to prevent tissue necrosis, has raised $30mm through the closing of its Series J venture round. New and lead investor DAG Ventures was joined by current backers, including Kleiner, Perkins, Caufield & Byers, Integral Capital Partners, Aperture Venture Partners, Cross Creek Capital, and New Science Ventures.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?